Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3348419rdf:typepubmed:Citationlld:pubmed
pubmed-article:3348419lifeskim:mentionsumls-concept:C0027713lld:lifeskim
pubmed-article:3348419lifeskim:mentionsumls-concept:C0022663lld:lifeskim
pubmed-article:3348419lifeskim:mentionsumls-concept:C0019010lld:lifeskim
pubmed-article:3348419lifeskim:mentionsumls-concept:C0042523lld:lifeskim
pubmed-article:3348419lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3348419lifeskim:mentionsumls-concept:C0392673lld:lifeskim
pubmed-article:3348419pubmed:issue3 Pt 2lld:pubmed
pubmed-article:3348419pubmed:dateCreated1988-4-19lld:pubmed
pubmed-article:3348419pubmed:abstractTextChronic verapamil administration has been shown to reduce the renal dysfunction, glomerular sclerosis, and mortality in partially nephrectomized rats; the mechanism is unknown. Therefore, the present micropuncture study examines the effect of verapamil on glomerular hemodynamics of Munich-Wistar rats 4 wk after five-sixths nephrectomy. Whole-kidney function was similar in nephrectomized rats treated with verapamil (Nx-VER) and saline (Nx-SAL), and glomerular filtration rate (GFR) was one-third of control. Both Nx-VER and Nx-SAL rats exhibited a similar degree of glomerular hyperperfusion and hyperfiltration. However, mean glomerular capillary hydrostatic pressure difference (delta P) was lower in Nx-VER than Nx-SAL rats (42.4 +/- 1.2 vs. 47.2 +/- 1.0 mmHg, P less than 0.005) because of an increase in Bowman's space hydrostatic pressure (PBS) in Nx-VER rats (15.5 +/- 0.8 vs. Nx-SAL 11.9 +/- 0.7 mmHg, P less than 0.005). Glomerular ultrafiltration coefficient (LpA) was significantly lower in Nx-SAL (P less than 0.005) than in Nx-VER or control rats. Urinary protein excretion and the magnitude of glomerular sclerosis in Nx-SAL and Nx-VER rats were not different. In conclusion, chronic VER administration normalizes LpA and reduces delta P, by increasing PBS, in Nx rats, alterations that neutralize each other, leading to the constancy of single-nephron GFR.lld:pubmed
pubmed-article:3348419pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3348419pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3348419pubmed:languageenglld:pubmed
pubmed-article:3348419pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3348419pubmed:citationSubsetIMlld:pubmed
pubmed-article:3348419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3348419pubmed:statusMEDLINElld:pubmed
pubmed-article:3348419pubmed:monthMarlld:pubmed
pubmed-article:3348419pubmed:issn0002-9513lld:pubmed
pubmed-article:3348419pubmed:authorpubmed-author:SchrierR WRWlld:pubmed
pubmed-article:3348419pubmed:authorpubmed-author:HarrisD CDClld:pubmed
pubmed-article:3348419pubmed:authorpubmed-author:MillerG JGJlld:pubmed
pubmed-article:3348419pubmed:authorpubmed-author:ShanleyP FPFlld:pubmed
pubmed-article:3348419pubmed:authorpubmed-author:PelayoJ CJClld:pubmed
pubmed-article:3348419pubmed:issnTypePrintlld:pubmed
pubmed-article:3348419pubmed:volume254lld:pubmed
pubmed-article:3348419pubmed:ownerNLMlld:pubmed
pubmed-article:3348419pubmed:authorsCompleteYlld:pubmed
pubmed-article:3348419pubmed:paginationF425-31lld:pubmed
pubmed-article:3348419pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3348419pubmed:meshHeadingpubmed-meshheading:3348419-...lld:pubmed
pubmed-article:3348419pubmed:meshHeadingpubmed-meshheading:3348419-...lld:pubmed
pubmed-article:3348419pubmed:meshHeadingpubmed-meshheading:3348419-...lld:pubmed
pubmed-article:3348419pubmed:meshHeadingpubmed-meshheading:3348419-...lld:pubmed
pubmed-article:3348419pubmed:meshHeadingpubmed-meshheading:3348419-...lld:pubmed
pubmed-article:3348419pubmed:meshHeadingpubmed-meshheading:3348419-...lld:pubmed
pubmed-article:3348419pubmed:meshHeadingpubmed-meshheading:3348419-...lld:pubmed
pubmed-article:3348419pubmed:meshHeadingpubmed-meshheading:3348419-...lld:pubmed
pubmed-article:3348419pubmed:meshHeadingpubmed-meshheading:3348419-...lld:pubmed
pubmed-article:3348419pubmed:meshHeadingpubmed-meshheading:3348419-...lld:pubmed
pubmed-article:3348419pubmed:meshHeadingpubmed-meshheading:3348419-...lld:pubmed
pubmed-article:3348419pubmed:meshHeadingpubmed-meshheading:3348419-...lld:pubmed
pubmed-article:3348419pubmed:meshHeadingpubmed-meshheading:3348419-...lld:pubmed
pubmed-article:3348419pubmed:year1988lld:pubmed
pubmed-article:3348419pubmed:articleTitleGlomerular hemodynamic adaptations in remnant nephrons: effects of verapamil.lld:pubmed
pubmed-article:3348419pubmed:affiliationDepartment of Pediatrics, University of Colorado Medical School, Denver 80262.lld:pubmed
pubmed-article:3348419pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3348419pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3348419pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3348419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3348419lld:pubmed